BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol. 2006;78:53-59. [PMID: 16299727 DOI: 10.1002/jmv.20503] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Alavian SM, Miri SM, Hollinger FB, Jazayeri SM. Occult Hepatitis B (OBH) in Clinical Settings. Hepat Mon 2012;12:e6126. [PMID: 23087749 DOI: 10.5812/hepatmon.6126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
2 Chandra PK, Banerjee A, Datta S, Chakravarty R. G1862T mutation among hepatitis B virus-infected individuals: association with viral genotypes and disease outcome in Kolkata, Eastern India. Intervirology. 2007;50:173-180. [PMID: 17259736 DOI: 10.1159/000098960] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
3 Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya SK, Chakravarty R. Frequency and significance of hepatitis B virus surface gene variant circulating among ‘antiHBc only’ individuals in Eastern India. J Clin Virol. 2007;40:312-317. [PMID: 17997353 DOI: 10.1016/j.jcv.2007.08.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
4 Huang X, Qin Y, Li W, Shi Q, Xue Y, Li J, Liu C, Hollinger FB, Shen Q. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B. J Med Virol. 2013;85:979-986. [PMID: 23588723 DOI: 10.1002/jmv.23556] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
5 Kupek E, Petry A. Comparison of epidemiological methods for estimation of hepatitis B incidence and residual risk for blood donors in southern Brazil. J Transfus 2011;2011:985383. [PMID: 25346858 DOI: 10.4061/2011/985383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Grant J, Agbaji O, Kramvis A, Yousif M, Auwal M, Penugonda S, Ugoagwu P, Murphy R, Hawkins C. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians. Trop Med Int Health 2017;22:744-54. [PMID: 28376292 DOI: 10.1111/tmi.12873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sengupta I, Das D, Singh SP, Chakravarty R, Das C. Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence. J Biol Chem. 2017;292:20379-20393. [PMID: 29046350 DOI: 10.1074/jbc.m117.796839] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
8 Zhang Z, Zhang L, Dai Y, Jin L, Sun B, Su Q, Li X. Occult hepatitis B virus infection among people with a family history of chronic hepatitis B virus infection. J Med Virol. 2015;87:1890-1898. [PMID: 25964194 DOI: 10.1002/jmv.24245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143:400-407. [PMID: 22580098 DOI: 10.1053/j.gastro.2012.05.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
10 Lin C, Kao J. Intrafamilial transmission of hepatitis B virus infection: Letters to the Editor. Journal of Gastroenterology and Hepatology 2007;22:765-6. [DOI: 10.1111/j.1440-1746.2007.04825.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, Maes P, Vanwijngaerden E, Nevens F, Van Ranst M. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection. J Med Virol. 2011;83:1876-1884. [PMID: 21915860 DOI: 10.1002/jmv.22174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
12 Sarkar N, Pal A, Das D, Saha D, Biswas A, Bandopadhayay B, Chakraborti M, Ghosh M, Chakravarty R. Virological Characteristics of Acute Hepatitis B in Eastern India: Critical Differences with Chronic Infection. PLoS One 2015;10:e0141741. [PMID: 26571502 DOI: 10.1371/journal.pone.0141741] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
13 Raouf HE, Yassin AS, Megahed SA, Ashour MS, Mansour TM. Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients. J Viral Hepat. 2015;22:103-111. [PMID: 24754376 DOI: 10.1111/jvh.12260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Chen C, Changchien C, Lee C, Tung W, Hung C, Hu T, Wang J, Wang J, Lu S. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer 2009;125:621-9. [DOI: 10.1002/ijc.24416] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
15 Chen SJ, Zhao YX, Fang Y, Xu WZ, Ma YX, Song ZW, Teng X, Gu HX. Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. Virus Res. 2012;163:197-201. [PMID: 21963662 DOI: 10.1016/j.virusres.2011.09.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
16 Powell EA, Gededzha MP, Rentz M, Rakgole NJ, Selabe SG, Seleise TA, Mphahlele MJ, Blackard JT. Mutations associated with occult hepatitis B in HIV-positive South Africans. J Med Virol 2015;87:388-400. [PMID: 25164924 DOI: 10.1002/jmv.24057] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
17 Zhang Z, Zhang L, Dai Y, Zhang Y, Li J, Li X. Occult hepatitis B virus infection: influence of S protein variants. Virol J 2016;13:10. [PMID: 26786229 DOI: 10.1186/s12985-016-0464-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
18 Foaud H, Maklad S, Mahmoud F, El-karaksy H. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis. Infection 2015;43:307-14. [DOI: 10.1007/s15010-015-0733-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
19 Martin CM, Welge JA, Shire NJ, Rouster SD, Shata MT, Sherman KE, Blackard JT. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. J Viral Hepat. 2010;17:588-597. [PMID: 19889143 DOI: 10.1111/j.1365-2893.2009.01214.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
20 Cowie BC. Is there an optimal genetic target for molecular analysis of hepatitis B virus transmission? J Clin Microbiol 2006;44:3051. [PMID: 16891543 DOI: 10.1128/JCM.01014-06] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, Sarin SK. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol. 2009;24:588-598. [PMID: 19207682 DOI: 10.1111/j.1440-1746.2008.05727.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
22 Datta S, Banerjee A, Chandra PK, Chakravarty R. Selecting a genetic region for molecular analysis of hepatitis B virus transmission. J Clin Microbiol. 2007;45:687; author reply 688. [PMID: 17277176 DOI: 10.1128/jcm.02046-06] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
23 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-1125/1/142] [Reference Citation Analysis]
24 Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008;5:156. [PMID: 19099581 DOI: 10.1186/1743-422X-5-156] [Cited by in Crossref: 79] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
25 Beale MA, Ijaz S, Tedder RS. The genetic backbone modulates the phenotype of hepatitis B surface antigen mutants. J Gen Virol 2010;91:68-73. [PMID: 19759242 DOI: 10.1099/vir.0.013078-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
26 Su H, Zhang Y, Xu D, Wang B, Zhang L, Li D, Xiao D, Li F, Zhang J, Yan Y. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. PLoS One. 2013;8:e70768. [PMID: 23951004 DOI: 10.1371/journal.pone.0070768] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
27 Kar P, Asim M, Sarma MP, Patki PS. HD-03/ES: A promising herbal drug for HBV antiviral therapy. Antiviral Research 2009;84:249-53. [DOI: 10.1016/j.antiviral.2009.09.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Gunardi H, Iskandar MY, Turyadi, Ie SI, Dwipoerwantoro PG, Gani RA, Muljono DH. Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission. Hepatol Int 2017;11:96-104. [PMID: 27624502 DOI: 10.1007/s12072-016-9764-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
30 Pal A, Panigrahi R, Biswas A, Datta S, Sarkar N, Guha SK, Saha B, Banerjee A, Chakrabarti S, Chakravarty R. Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients. Virology. 2013;436:134-142. [PMID: 23228859 DOI: 10.1016/j.virol.2012.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
31 Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, Chakrabarti S, De BK, Chakravarty R. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat. 2009;16:749-756. [PMID: 19457142 DOI: 10.1111/j.1365-2893.2009.01129.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
32 Miyagawa M, Minami M, Fujii K, Sendo R, Mori K, Shimizu D, Nakajima T, Yasui K, Itoh Y, Taniwaki M. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab. J Med Virol. 2008;80:2069-2078. [PMID: 19040281 DOI: 10.1002/jmv.21311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
33 Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK, Mahapatra PK, Patnaik B, Chakrabarti S, Chakravarty R. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J. 2010;7:204. [PMID: 20799931 DOI: 10.1186/1743-422x-7-204] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
34 Panigrahi R, Biswas A, Banerjee A, Singh SP, Panigrahi MK, Roque-Afonso AM, Das HS, Mahapatra PK, Chakrabarti S, Chakravarty R. Subgenotype D5, BCP and MHR mutations in hepatic complications among hepatitis B virus infected patients from Orissa, India. Infect Genet Evol. 2012;12:1622-1629. [PMID: 22820088 DOI: 10.1016/j.meegid.2012.06.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
35 Saikia A, Bose M, Barman NN, Deka M, Thangkhiew RS, Bose S. Molecular epidemiology of HBV infection in chronic hepatitis B virus infected patients in northeast India. J Med Virol 2015;87:1539-48. [PMID: 25919572 DOI: 10.1002/jmv.24207] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
36 Panigrahi R, Majumder S, Gooptu M, Biswas A, Datta S, Chandra P, Banerjee A, Chakrabarti S, Bandopadhyay D, De B, Chakravarty R. Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. Annals of Hepatology 2012;11:870-5. [DOI: 10.1016/s1665-2681(19)31412-7] [Cited by in Crossref: 14] [Article Influence: 1.6] [Reference Citation Analysis]
37 Datta S, Banerjee A, Chandra PK, Mahapatra PK, Chakrabarti S, Chakravarty R. Drug trafficking routes and hepatitis B in injection drug users, Manipur, India. Emerg Infect Dis 2006;12:1954-7. [PMID: 17326951 DOI: 10.3201/eid1212.060425] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
38 Datta S, Chandra PK, Banerjee A, Chakravarty R, Murhekar KM, Murhekar MV. Predominance of hepatitis B virus genotype C among Karens, the 'old settlers' of Andaman and Nicobar Islands, India. Arch Virol 2007;152:1223-8. [PMID: 17216140 DOI: 10.1007/s00705-006-0910-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
39 Biswas A, Chandra PK, Datta S, Panigrahi R, Banerjee A, Chakrabarti S, Biswas K, Patra D, Bhattacharya P, Biswas K, Chakravarty R. Frequency and distribution of hepatitis B virus genotypes among eastern Indian voluntary blood donors: Association with precore and basal core promoter mutations. Hepatology Research 2009;39:53-9. [DOI: 10.1111/j.1872-034x.2008.00403.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
40 Batham A, Gupta MA, Rastogi P, Garg S, Sreenivas V, Puliyel JM. Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis. Indian J Pediatr. 2009;76:1247-1257. [PMID: 20108060 DOI: 10.1007/s12098-009-0246-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
41 Hu LP, Liu DP, Chen QY, Harrison TJ, He X, Wang XY, Li H, Tan C, Yang QL, Li KW, Fang ZL. Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection. PLoS One 2015;10:e0138552. [PMID: 26457811 DOI: 10.1371/journal.pone.0138552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
42 Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol 2007;40:255-8. [PMID: 17869170 DOI: 10.1016/j.jcv.2007.08.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
43 Banerjee A, Datta S, Chandra PK, Roychowdhury S, Panda CK, Chakravarty R. Distribution of hepatitis B virus genotypes: phylogenetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, Eastern India. World J Gastroenterol 2006;12:5964-71. [PMID: 17009394 DOI: 10.3748/wjg.v12.i37.5964] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
44 Candotti D, El Chaar M, Allain J. Transfusion transmission of hepatitis B virus: still learning more about it: Transfusion transmission of hepatitis B virus. ISBT Science Series 2011;6:234-40. [DOI: 10.1111/j.1751-2824.2011.01493.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-11] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 10.1] [Reference Citation Analysis]
46 Bloquel B, Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. J Med Virol. 2010;82:206-212. [PMID: 20029819 DOI: 10.1002/jmv.21685] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
47 Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Salehi M, Ahmadabadi BN, Kennedy D. Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection. Clin Res Hepatol Gastroenterol. 2011;35:554-559. [PMID: 21835725 DOI: 10.1016/j.clinre.2011.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]